How to Get Berinert (C1-esterase inhibitor, IV) Covered by UnitedHealthcare in New York: Complete Guide with Forms, Appeals, and Support Resources
Answer Box: Quick Path to Berinert Coverage
To get Berinert (C1-esterase inhibitor, IV) covered by UnitedHealthcare in New York: Submit prior authorization through OptumRx with confirmed HAE diagnosis (C1-INH deficiency labs or genetic variants), prescribed by immunologist/allergist for acute attacks only. Use CoverMyMeds for electronic PA or fax to 1-844-403-1027. If denied, request peer-to-peer review within 24 hours, then file internal appeal via UHC Provider Portal within 180 days. New York residents can pursue external appeal through DFS within 4 months of final denial ($25 fee, refunded if overturned).
Table of Contents
- Start Here: Verify Your Plan & Find Forms
- Prior Authorization Forms & Requirements
- Submission Portals & Electronic Options
- Fax Numbers & Mailing Addresses
- Specialty Pharmacy Network & Home Infusion
- Support Phone Lines & What to Ask
- New York External Appeals & Consumer Help
- Appeals Playbook: Internal to External
- Common Denial Reasons & How to Fix Them
- Frequently Asked Questions
Start Here: Verify Your Plan & Find Forms
Before submitting your Berinert prior authorization, confirm your UnitedHealthcare plan type and locate the current forms:
Plan Verification Steps:
- Check your insurance card for "OptumRx" (pharmacy benefit manager)
- Log into UHC Provider Portal to verify specialty drug coverage
- Confirm you have a New York address on file for state-specific appeal rights
Current Policy & Forms:
- Coverage Policy: PA-Med-Nec-Berinert.pdf (effective through 4/2025)
- Notification Form: PA-Notification-Berinert.pdf
- General OptumRx PA Form: Available at OptumRx forms page
Prior Authorization Forms & Requirements
Coverage Criteria for Berinert (2025 Program 2211-6)
Initial Authorization (12 months):
- Confirmed HAE diagnosis via:
- Type I/II HAE: C1-INH antigenic OR functional level below normal laboratory standard
- HAE with normal C1-INH: Genetic variants (factor XII, angiopoietin-1, plasminogen-1, kininogen-1, myoferlin, or heparan sulfate-glucosamine 3-O-sulfotransferase 6)
- Prescribed for acute HAE attacks only (not prophylaxis)
- Prescribed by immunologist or allergist
- Not used concurrently with Firazyr or Ruconest
Reauthorization Requirements:
- Documented positive clinical response to Berinert
- Continued acute treatment indication
- Same prescriber specialty requirement
Tip: UnitedHealthcare may approve requests based on prior claim history and ICD-10 codes through automated processes, even without meeting all traditional criteria.
Submission Portals & Electronic Options
Electronic Submission (Recommended)
CoverMyMeds Portal:
- Visit CoverMyMeds OptumRx forms
- Select "Berinert" from specialty drug list
- Complete member details, diagnosis (ICD-10: D84.1), and prior therapy history
- Upload supporting documents (labs, clinic notes, denial letters)
OptumRx PreCheck:
- Automated approval for qualifying requests (~29 seconds if criteria met)
- Integrated with major EMR systems for seamless submission
UHC Provider Portal:
- Log in at uhcprovider.com
- Navigate to "Prior Auth & Advance Notification"
- Use TrackIt system for real-time status updates
Fax Numbers & Mailing Addresses
OptumRx Submission Contacts
Standard Prior Authorization:
- Fax: 1-844-403-1027
- Include complete member information, prescriber details, and clinical documentation
Urgent/Expedited Requests:
- Phone: 1-800-711-4555
- Required for life-threatening laryngeal HAE attacks
- 72-hour decision timeline for urgent cases
Cover Sheet Tips:
- Include member name, ID number, and New York address
- Mark "URGENT" for laryngeal attacks or imminent health risk
- Reference "Berinert C1-esterase inhibitor for HAE" clearly
- Attach physician attestation for medical necessity
Specialty Pharmacy Network & Home Infusion
UnitedHealthcare-Approved Home Infusion Providers in New York
| Provider | Phone | Services | Notes |
|---|---|---|---|
| Amber Specialty Pharmacy | 888-370-1724 | Nationwide, NY-covered | Handles Berinert-like biologics |
| KabaFusion | 800-435-3020 | Home infusion in NY | IVIG/biologics support |
| Option Care | 866-827-8203 | NY home infusion | Verify Berinert availability |
| Optum Infusion Services | 877-306-4036 | UHC-affiliated | Direct billing capability |
| Soleo Health | 833-765-3648 | Home infusion services | Specialty drug delivery |
Home Infusion Requirements (Effective July 1, 2024):
- Must use in-network providers for NY situs groups
- Providers handle prior authorization support
- Self-infusion training included
- Emergency backup protocols for laryngeal attacks
Infusion Center Options
UHS Binghamton Infusion Center:
- Address: 10-42 Mitchell Ave, Krembs 6th Floor, Binghamton, NY
- Phone: 607-763-5855 (prior auth: 607-763-5985)
- Hours: Mon-Fri 7am-7pm, weekends 8am-4pm
Support Phone Lines & What to Ask
Key Contact Numbers
Member Services: 1-800-624-8822
- Verify benefits and formulary status
- Check prior authorization status
- Request denial letters and appeal forms
Provider Services: 1-877-842-3210
- Clinical questions and peer-to-peer requests
- Expedited review requests
- Appeal submission guidance
OptumRx Specialty: 1-800-711-4555
- Specialty drug prior authorizations
- Home infusion coordination
- Urgent medication needs
Questions to Ask
When Calling Member Services:
- "Is Berinert covered under my pharmacy benefit?"
- "What tier is Berinert on my formulary?"
- "Do I need prior authorization for acute HAE treatment?"
- "What's my current prior authorization status?"
When Requesting Peer-to-Peer:
- "I need to schedule a peer-to-peer review for Berinert denial"
- "Can you expedite this for a patient with laryngeal HAE attacks?"
- "What clinical information should I prepare for the medical director?"
New York External Appeals & Consumer Help
New York Department of Financial Services (DFS) External Appeal
Eligibility: Available after exhausting UnitedHealthcare's internal appeal process for denials based on:
- Medical necessity
- Experimental/investigational treatment
- Non-formulary drugs
- Out-of-network services
Filing Requirements:
- Submit within 4 months of final internal denial
- Use DFS External Appeal Portal
- Include physician attestation form (mandatory)
- Fee: $25 (waived for Medicaid; refunded if overturned)
Timeline:
- Standard: 30 days
- Expedited: 72 hours (urgent medical needs)
- Non-formulary drugs: 24 hours
Free Consumer Assistance
Community Health Advocates (CHA):
- Phone: 888-614-5400
- Free counseling on insurance denials and appeals
- Assistance with DFS external appeal filing
Healthcare Appeals Ombudsman (New 2025):
- Phone: 1-800-NYS-APPEAL
- Free guidance under March 2025 reform law
- 72-hour urgent resolution with penalties for delays
Appeals Playbook: Internal to External
Step-by-Step Appeal Process
1. Peer-to-Peer Review (First Step)
- Request within 24 hours of denial
- 5-10 minute call with UHC medical director
- Present clinical rationale and HAE attack severity
- Timeline: Inpatient within 3 business days, outpatient within 21 days
2. Level 1 Internal Appeal
- Submit within 180 days via UHC Provider Portal
- Include denial letter, medical records, medical necessity letter
- Address specific denial reasons (step therapy, diagnosis documentation)
- Timeline: 10-15 business days standard, expedited if urgent
3. Level 2 Internal Appeal
- File within 60 days of Level 1 denial
- Add new evidence (specialist consults, additional studies)
- Timeline: 15-20 business days
4. New York External Appeal
- File with DFS within 4 months of final internal denial
- Independent medical expert review
- Decision is binding on UnitedHealthcare
Common Denial Reasons & How to Fix Them
| Denial Reason | How to Overturn | Required Documentation |
|---|---|---|
| Use for prophylaxis | Emphasize acute attack treatment only | Attack frequency logs, ER visits for HAE |
| Missing HAE documentation | Provide complete diagnostic workup | C1-INH levels, C4 levels, genetic testing |
| Quantity limits per attack | Justify weight-based dosing | Patient weight, 20 IU/kg calculation, FDA label |
| Site-of-care restrictions | Document home infusion medical necessity | Training completion, emergency backup plan |
| Step therapy requirement | Document contraindications to alternatives | Allergy history, prior treatment failures |
Medical Necessity Letter Checklist
Essential Elements:
- HAE diagnosis with lab confirmation
- Attack frequency and anatomical locations
- Prior therapy failures or contraindications
- Berinert dosing rationale (20 IU/kg IV)
- Self-administration training plan
- Emergency protocol for laryngeal attacks
When navigating complex insurance appeals for specialty medications like Berinert, many patients and providers benefit from expert guidance. Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals by analyzing denial letters, plan policies, and clinical notes to draft point-by-point rebuttals aligned with each payer's specific requirements.
Frequently Asked Questions
Q: How long does UnitedHealthcare prior authorization take for Berinert in New York? A: Standard decisions take 72 hours. Urgent cases (life-threatening laryngeal attacks) receive expedited review, typically within 24-48 hours.
Q: What if Berinert is non-formulary on my plan? A: File a formulary exception request with medical necessity documentation. If denied, you can appeal through New York's external appeal process for non-formulary drug decisions within 24 hours.
Q: Can I get expedited appeals for HAE attacks? A: Yes. Laryngeal HAE attacks qualify for expedited internal appeals and 24-hour external appeals through New York DFS due to life-threatening nature.
Q: Does step therapy apply if I've tried other HAE treatments outside New York? A: Document all prior therapies with dates, doses, and outcomes. UnitedHealthcare accepts out-of-state treatment history with proper clinical documentation.
Q: What's the cost of Berinert without insurance approval? A: Cash price per vial is often in five figures. Contact CSL Behring patient support for copay assistance and foundation grant programs.
Q: Can I appeal if my doctor isn't an immunologist or allergist? A: UnitedHealthcare requires specialist prescribing. If your current doctor isn't a specialist, request a referral or have them coordinate with an immunologist/allergist for prescription.
Q: How do I track my appeal status? A: Use UHC Provider Portal's TrackIt system for real-time updates. For external appeals, contact DFS at 1-800-400-8882.
Q: What happens if I need Berinert while my appeal is pending? A: For urgent laryngeal attacks, go to the emergency room immediately. Hospital administration is covered without prior authorization. Request expedited appeal review citing imminent health risk.
The appeals process can feel overwhelming, but New York residents have strong protections and multiple avenues for overturning insurance denials. Counterforce Health helps patients and clinicians navigate these complex processes by identifying specific denial reasons and crafting targeted responses with the right clinical evidence and regulatory citations.
Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider and insurance plan for specific coverage decisions. For additional assistance with insurance appeals in New York, contact Community Health Advocates at 888-614-5400 or the New York Department of Financial Services at 1-800-400-8882.
Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.